1 jan 2011 ano - New event

Descrição:

The first-in-class gene therapy drug, pCMV-vegf165, is registered in Russia for the treatment of peripheral artery disease, including the advanced stage of critical limb ischemia. The United Nations declaration on non-communicable diseases (NCD's) changes the global approach to these diseases, of which cardiovascular disease is the greatest contributor.

Adicionado na linha do tempo:

Data: